1. Academic Validation
  2. The location of DCX mutations predicts malformation severity in X-linked lissencephaly

The location of DCX mutations predicts malformation severity in X-linked lissencephaly

  • Neurogenetics. 2008 Oct;9(4):277-85. doi: 10.1007/s10048-008-0141-5.
Pierre-Louis Leger 1 Isabelle Souville Nathalie Boddaert Caroline Elie Jean Marc Pinard Perrine Plouin Marie Laure Moutard Vincent des Portes Hilde Van Esch Sylvie Joriot Jean Louis Renard Jamel Chelly Fiona Francis Cherif Beldjord Nadia Bahi-Buisson
Affiliations

Affiliation

  • 1 Département de Pédiatrie, Hopital Necker Enfants Malades, AP-HP, Université Paris Descartes, Paris, France.
Abstract

Lissencephaly spectrum (LIS) is one of the most severe neuronal migration disorders that ranges from agyria/pachygyria to subcortical band heterotopia. Approximately 80% of patients with the LIS spectrum carry mutations in either the LIS1 or DCX (doublecortin) genes which have an opposite gradient of severity. The aim of the study was to evaluate in detail the phenotype of DCX-associated lissencephaly and to look for genotype-phenotype correlations. Of the 180 male patients with DCX-related lissencephaly, 33 males (24 familial cases and nine cases with de novo mutations) were found with hemizygous DCX mutations and were clinically and genetically assessed here. DCX mutation analysis revealed that the majority of mutations were missense (79.2%), clustered in the two evolutionary conserved domains, N-DC and C-DC, of DCX. The most prominent radiological phenotype was an anteriorly predominant pachygyria or agyria (54.5%) although DCX-associated lissencephaly encompasses a complete range of LIS grades. The severity of neurological impairment was in accordance with the degree of agyria with severe cognitive impairment in all patients, inability to walk independently in over half and refractory epilepsy in more than a third. For genotype-phenotype correlations, patients were divided in two groups according to the location of DCX missense mutations. Patients with mutations in the C-DC domain tended to have a less severe lissencephaly (grade 4-5 in 58.3%) compared with those in the N-DC domain (grade 4-5 in 36.3%) although, in this dataset, this was not statistically significant (p = 0.12). Our evaluation suggests a putative correlation between phenotype and genotype. These data provide further clues to deepen our understanding of the function of the DCX protein and may give new insights into the molecular mechanisms that could influence the consequence of the mutation in the N-DC versus the C-DC domain of DCX.

Figures